Pasithea Therapeutics Corp.
KTTA
$0.7174
$0.00030.04%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.29% | -12.13% | -5.93% | 22.41% | -0.14% |
| Total Depreciation and Amortization | 0.00% | -0.37% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 123.05% | -74.79% | -46.38% | 10.99% | -38.52% |
| Change in Net Operating Assets | -220.23% | -30.54% | 190.88% | 5.70% | 43.61% |
| Cash from Operations | -26.61% | -25.08% | 21.71% | 22.74% | 6.53% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 253.92% | 551,100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 36.70% | -650.21% | -100.53% | -- | -- |
| Cash from Financing | 289.27% | 6,347.03% | -100.52% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | 203.69% | -834.48% | -383.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 218.61% | 35.14% | -274.97% | 134.48% | 6.48% |